1. Eckschlager T, Plch J, Stiborova M, Hrabeta J. Histone Deacetylase Inhibitors as Anticancer Drugs. Int J Mol Sci 2017; 18: 1-25.
2. Di Martino S, Rainone A, Troise A et al. Overview of FDA-Approved Anti Cancer Drugs Used for Targeted Therapy. World Cancer Res J 2015; 2: e553. Available online at https://www.wcrj.net/article/553 (accessed February 2020).
3. Arora A, Scholar E M. Role of Tyrosine Kinase Inhibitors in Cancer Therapy. J Pharmacol Exp Ther 2005; 315: 971-979.
4. National Cancer Institute. Targeted Cancer Therapies. 2018. Available at https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet (accessed October 2018).
5. Research Advocacy Network. Targeted Therapies in Cancer. 2013. Available at http://www.researchadvocacy.org/sites/default/files/resources/TargetedTherapiesTutorial-Final.pdf (accessed October 2018).